Viewing Study NCT04842604


Ignite Creation Date: 2025-12-24 @ 7:56 PM
Ignite Modification Date: 2025-12-30 @ 1:51 AM
Study NCT ID: NCT04842604
Status: COMPLETED
Last Update Posted: 2023-12-18
First Post: 2021-04-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-05-17
Start Date Type: ACTUAL
Primary Completion Date: 2022-12-02
Primary Completion Date Type: ACTUAL
Completion Date: 2022-12-02
Completion Date Type: ACTUAL
First Submit Date: 2021-04-08
First Submit QC Date: None
Study First Post Date: 2021-04-13
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-11-27
Results First Submit QC Date: None
Results First Post Date: 2023-12-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-11-27
Last Update Post Date: 2023-12-18
Last Update Post Date Type: ACTUAL